Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1...

Area of Science:

• Endocrinology
• Diabetes Management
• Medical Device Utilization

Background:

• Previous research indicated limited continuous glucose monitoring (CGM) use, around 30%, primarily in pediatric populations or those treated at academic centers.
• A gap exists in understanding national trends of CGM adoption across diverse age groups and healthcare settings.

Purpose of the Study:

• To analyze national trends in CGM utilization among commercially insured individuals with type 1 diabetes, encompassing both children and adults.
• To identify changes in CGM uptake over a decade.

Main Methods:

• Utilized national claims data from commercially insured individuals diagnosed with type 1 diabetes.
• Analyzed CGM utilization rates during two distinct periods: 2010-2013 and 2016-2019.

Main Results:

• CGM utilization significantly increased from 20.12% in 2010-2013 to 49.78% in 2016-2019.
• This represents a 2.5-fold increase in CGM adoption over less than 10 years.
• The study provides a national perspective on CGM use beyond specialized pediatric or academic settings.

Conclusions:

• National CGM utilization among commercially insured patients with type 1 diabetes has substantially increased.
• Further research is needed to identify specific populations with lower CGM uptake to inform targeted interventions.
• Increased CGM use signifies a potential shift towards more advanced glucose management strategies in type 1 diabetes care.